Clinical trial Recruiting at 1 site Observational Ages 18 to 45

Obesity and Muscle Signaling After a Single Workout and Protein Drink

Official title: Understanding the Effects of Obesity on Autophagic and mTORC1 Signalling Following Resistance Exercise and Protein Ingestion in Skeletal Muscle.

Run by University of Birmingham · NCT07774676 · Data updated 2026-11-12

This study tests whether skeletal muscle signaling after resistance exercise and protein intake differs between lean adults and those who are overweight or obese.

More Overweight and Obese Adults trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexAll
Enrollment24 (estimated)
SponsorUniversity of Birmingham
Academic / other
Locations1 site (Birmingham)
StatusRecruiting
StartedApril 15, 2026
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedAugust 19, 2026
Trial IDNCT07774676 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18-45 with lean BMI (18.5-24.9) or BMI >28, who are physically active but not currently in structured exercise programs.

Probably not a fit

Individuals with obesity who are on certain medications or have conditions listed in the exclusion criteria may not experience direct benefits from the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will compare how skeletal muscle responds to a bout of single-leg resistance exercise and a protein-rich drink in two groups: lean adults and adults with overweight or obesity. Participants will provide muscle samples from both legs before and after the activities to analyze signaling pathways related to muscle growth and autophagy. The study uses muscle biopsies, blood samples, a protein beverage, a resistance exercise session, and body composition assessments to understand group differences. Results may help tailor strategies to improve muscle quality in obesity. The project is conducted at the University of Birmingham with healthy adults in the defined age range and BMI categories.

Why it matters

Potential benefit: If successful, findings could inform targeted approaches to enhance muscle growth and metabolic health in people with obesity.

How similar studies have gone: Prior studies suggest obesity can alter muscle signaling after exercise, but direct single-leg, within-subject comparisons with paired proteomic analyses are relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age - 18-45yrs
* BMI - 18.5-24.9kg/m2 OR \>28kg/m2 (self-declaration, or calculated by research team based on height and weight)
* Weight Stable i.e. no change in weight of more than 5% in previous 6 months
* Meeting UK Physical activity guidelines (150 mins moderate or 75 mins vigorous activity/wk)
* Not involved in structured exercise training in previous 6 months
* No other diagnosed metabolic or neuromuscular conditions (self-declaration)

Exclusion Criteria:

* Currently using anti-diabetes medication (insulin, metformin, sulphonylureas, meglitinides, thiazolidinediones, DPP- 4 inhibitors, GLP-1 inhibitors).
* Currently taking cholesterol lowering medications (statins)
* Currently engaged in active weight loss programmes or using weight loss medication
* Chronic kidney disease (moderate to severe reduction in kidney function), defined as eGFR \<30 ml/min/1.73m2 identified by self declaration.
* Pregnant or breast feeding
* Currently using anti-coagulation medication
* Hypothyroidism
* Type 1 diabetes
* Current or recent weakness/injury to either leg that may affect muscle function or ability to exercise
* Current gastrointestinal issue/condition that may affect digestion and absorption of protein drink
* Individuals who follow a vegan diet or have intolerance/allergies to Whey protein.
* Previous adverse reaction to local anaethetic (lidocaine or marcaine).

Where it's running

  • School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham
    Birmingham, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.